Salveo Capital invests in PathogenDx
Salveo Capital, an alternative investment firm specialising in the legalised cannabis space, has acquired a minority equity interest in PathogenDx, a provider of DNA-based pathogen testing kits for the cannabis, botanical, food and agriculture industries. Financial terms of the transaction have not been disclosed. Founded in 2014, PathogenDx’s mission
